Use of Imaging Endpoints in Clinical Trials

作者：Gillam Linda D^*; Leipsic Jonathon; Weissman Neil J

来源：JACC: Cardiovascular Imaging , 2017, 10(3): 296-303.

DOI：10.1016/i.jcmg.2016.12.003

• cardiac computed
• tomography
• cardiac magnetic resonance
• imaging
• clinical trials
• core laboratory
• echocardiography
• imaging
• nuclear
• cardiology

Cardiovascular imaging is an integral component of many clinical trials beyond those for which the primary goal is to evaluate or validate imaging technologies. The scope of such trials is broad, ranging from those in which a medical, surgical, or interventional cardiovascular device or drug is being evaluated to those in which there is concern about cardiovascular adverse events complicating treatment for noncardiac conditions. This paper discusses study design as it pertains to the incorporation of imaging elements, the important role played by imaging core laboratories, the rationale for and approaches to involvement of imagers in clinical trials, and guidance by the U.S. Food and Drug Administration on imaging endpoints in clinical trials.

• 出版日期2017-3